Areas of Focus
- 靶向肿瘤相关巨噬细胞的基础和转化
- 药物递送系统和免疫治疗
Academic Background & Achievements
- 浙江大学硕士研究生导师
- 浙大一院特聘研究员
- 目前主持国家自然科学基金青年项目1项,浙江省自然科学基金青年项目1项
- 担任Exploration青年编委
- Journal for ImmunoTherapy of Cancer, Research, Cellular Signalling等多个杂志的审稿人
- 已发表的SCI文章total citation > 1000, H-index 18
Publications
- A multiomics analysis-assisted deep learning model identifies a macrophage-oriented module as a potential therapeutic target in colorectal cancer, Bao XW+, Li Q+, Chen D+, Dai XM+, et al., 2024
- Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment, Jin YZ+, Huang YY+, Ren H+, …Zhao P* & Dai XM*, 2024
- Induction of Tumor Ferroptosis-Dependent Immunity via an Injectable Attractive Pickering Emulsion Gel, Dai XM+*, J Zhang+, XW Bao+, et al., 2023
- An immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis, Bao XW+, Wang DY+, Dai XM+, et al., 2023
- Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma, Dai XM+, Guo YX+, Hu Y, et al., 2021
- Enhanced radiotherapy efficacy and induced anti-tumor immunity in HCC by improving hypoxia microenvironment using oxygen microcapsules, Dai XM+, Ruan J+; Guo YX+, et al., 2021
- Targeting CAMKII to reprogram tumor- associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel, Dai XM+, Meng JS+, Deng SK+, et al., 2020
- USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer, Dai XM+, Lu LS+, Deng SK, et al., 2020
- Association of PD-L1 and HIF-1 alpha Coexpression with Poor Prognosis in Hepatocellular Carcinoma, Dai XM+, Pi GL+, Yang SL*, et al., 2018
- Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma, Dai XM+, Xue J+, Hu JL, et al., 2017